2024-04-23 11:47 | CC:OPTI | Optimi Health Corp | 0.33 | News Release200 | Optimi partners with Kwantlen psilocybin research |
2024-04-15 12:53 | CC:OPTI | Optimi Health Corp | 0.255 | News Release200 | Optimi Health completes three batches of MDMA API |
2024-04-09 15:03 | CC:OPTI | Optimi Health Corp | 0.265 | News Release200 | Optimi Health signs psilocybin supply agreement |
2024-04-02 11:30 | CC:OPTI | Optimi Health Corp | 0.245 | News Release200 | Optimi receives GMP analysis certificate for psilocybin |
2024-03-26 11:28 | CC:OPTI | Optimi Health Corp | 0.23 | News Release200 | Optimi to supply MDMA to Tel Aviv University |
2024-03-01 00:40 | CC:OPTI | Optimi Health Corp | 0.265 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2024-03-01 00:40 | CC:OPTI | Optimi Health Corp | 0.265 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2024-02-28 11:52 | CC:OPTI | Optimi Health Corp | 0.29 | News Release200 | Optimi Health closes $555,010 first financing tranche |
2024-02-12 10:06 | CC:OPTI | Optimi Health Corp | 0.34 | News Release200 | Optimi Health releases MDMA production video |
2024-02-08 11:32 | CC:OPTI | Optimi Health Corp | 0.31 | News Release200 | Optimi Health arranges $1.5-million financing |
2024-02-06 11:39 | CC:OPTI | Optimi Health Corp | | News Release200 | Optimi Health to hold webinar Feb. 13 |
2024-01-19 09:48 | CC:OPTI | Optimi Health Corp | 0.305 | News Release200 | Optimi gets OK to increase quantities under HC licence |
2024-01-03 10:25 | CC:OPTI | Optimi Health Corp | 0.30 | News Release200 | Optimi receives precursor licence to formulate MDMA |
2023-12-07 10:50 | CC:OPTI | Optimi Health Corp | 0.16 | News Release200 | Optimi Health signs supply deal with Sunshine Earth |
2023-11-28 12:51 | CC:OPTI | Optimi Health Corp | 0.19 | News Release200 | Optimi Health harvests 8 natural psilocybin genetics |
2023-11-10 10:01 | CC:OPTI | Optimi Health Corp | 0.165 | News Release200 | Optimi Health resolves supply agreement dispute |
2023-11-07 13:16 | CC:OPTI | Optimi Health Corp | 0.16 | News Release200 | Optimi appoints Chase as chief science officer |
2023-11-02 13:57 | CC:OPTI | Optimi Health Corp | 0.17 | News Release200 | Optimi Health arranges $1-million debt financing |
2023-09-14 16:18 | CC:OPTI | Optimi Health Corp | 0.19 | News Release200 | Optimi Health cheers phase 3 MAPS PTSD trial results |
2023-09-07 11:15 | CC:OPTI | Optimi Health Corp | 0.19 | News Release200 | Optimi receives licence amendment from Health Canada |
2023-09-05 14:34 | CC:OPTI | Optimi Health Corp | 0.19 | News Release200 | Optimi Health arranges $1-million debt financing |
2023-08-22 18:35 | CC:OPTI | Optimi Health Corp | 0.20 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
2023-08-22 18:33 | CC:OPTI | Optimi Health Corp | 0.20 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-08-10 13:36 | CC:OPTI | Optimi Health Corp | 0.195 | News Release200 | Optimi Health arranges $3-million debt financing |
2023-08-01 14:27 | CC:OPTI | Optimi Health Corp | 0.19 | News Release200 | Optimi completes GMP psilocybin extraction process |
2023-07-27 12:38 | CC:OPTI | Optimi Health Corp | 0.205 | News Release200 | Optimi Health receives supply deal termination notice |
2023-06-15 11:37 | CC:OPTI | Optimi Health Corp | 0.21 | News Release200 | Optimi Health to supply MDMA for Numinus trial |
2023-05-25 20:07 | CC:OPTI | Optimi Health Corp | 0.23 | SEDAR MD & A815 | SEDAR MD & A |
2023-05-25 20:01 | CC:OPTI | Optimi Health Corp | 0.23 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
2023-05-17 10:05 | CC:OPTI | Optimi Health Corp | 0.22 | News Release200 | Optimi Health completes 300 kg mushroom harvest |
2023-05-10 11:51 | CC:OPTI | Optimi Health Corp | 0.235 | News Release200 | Optimi Health receives natural health product licence |
2023-05-04 11:44 | CC:OPTI | Optimi Health Corp | 0.225 | News Release200 | Optimi Health signs $1.2M psilocybin supply contract |